v3.26.1
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Total Shareholders' Equity
Common Stock
APIC
AOCI
Retained Earnings
NCI
Beginning Balance (in shares) at Dec. 31, 2024     169        
Beginning balance at Dec. 31, 2024 $ 3,992 $ 3,949 $ 2 $ 1,174 $ (351) $ 3,124 $ 43
Increase (Decrease) in Shareholders' Equity              
Net earnings (232) (241)       (241) 9
OCI 26 26     26    
Contributions from NCI, net of distributions 8           8
Other NCI transactions (1)           (1)
Stock-based plan activity (in shares)     1        
Stock-based plan activity 1 1   1      
Repurchase of common stock (in shares)     (4)        
Repurchase of common stock (144) (144)   (144)      
Ending Balance (in shares) at Mar. 31, 2025     166        
Ending balance at Mar. 31, 2025 3,650 3,591 $ 2 1,031 (325) 2,883 59
Beginning Balance (in shares) at Dec. 31, 2024     169        
Beginning balance at Dec. 31, 2024 3,992 3,949 $ 2 1,174 (351) 3,124 43
Increase (Decrease) in Shareholders' Equity              
Net earnings 2,206            
OCI 72            
Ending Balance (in shares) at Jun. 30, 2025     162        
Ending balance at Jun. 30, 2025 5,978 5,949 $ 2 887 (279) 5,339 29
Beginning Balance (in shares) at Mar. 31, 2025     166        
Beginning balance at Mar. 31, 2025 3,650 3,591 $ 2 1,031 (325) 2,883 59
Increase (Decrease) in Shareholders' Equity              
Net earnings 2,438 2,460       2,460 (22)
OCI 46 46     46    
Contributions from NCI, net of distributions (8)           (8)
Stock-based plan activity 9 9   9      
Repurchase of common stock (in shares)     (4)        
Repurchase of common stock (157) (157)   (153)   (4)  
Ending Balance (in shares) at Jun. 30, 2025     162        
Ending balance at Jun. 30, 2025 5,978 5,949 $ 2 887 (279) 5,339 29
Beginning Balance (in shares) at Dec. 31, 2025     152        
Beginning balance at Dec. 31, 2025 3,277 3,244 $ 2 443 (265) 3,064 33
Increase (Decrease) in Shareholders' Equity              
Net earnings 165 160       160 5
OCI (21) (21)     (21)    
Contributions from NCI, net of distributions 41           41
Stock-based plan activity (in shares)     1        
Stock-based plan activity 10 10   10      
Repurchase of common stock (in shares)     (11)        
Repurchase of common stock (521) (521) $ (1) (453)   (67)  
Ending Balance (in shares) at Mar. 31, 2026     142        
Ending balance at Mar. 31, 2026 2,951 2,872 $ 1 0 (286) 3,157 79
Beginning Balance (in shares) at Dec. 31, 2025     152        
Beginning balance at Dec. 31, 2025 3,277 3,244 $ 2 443 (265) 3,064 33
Increase (Decrease) in Shareholders' Equity              
Net earnings 289            
OCI (28)            
Ending Balance (in shares) at Jun. 30, 2026     136        
Ending balance at Jun. 30, 2026 2,785 2,686 $ 1 0 (293) 2,978 99
Beginning Balance (in shares) at Mar. 31, 2026     142        
Beginning balance at Mar. 31, 2026 2,951 2,872 $ 1 0 (286) 3,157 79
Increase (Decrease) in Shareholders' Equity              
Net earnings 123 114       114 9
OCI (7) (7)     (7)    
Contributions from NCI, net of distributions 11           11
Stock-based plan activity 10 10   10      
Repurchase of common stock (in shares)     (6)        
Repurchase of common stock (303) (303)   (10)   (293)  
Ending Balance (in shares) at Jun. 30, 2026     136        
Ending balance at Jun. 30, 2026 $ 2,785 $ 2,686 $ 1 $ 0 $ (293) $ 2,978 $ 99